{"title":"The point of view of a low prevalence country: The Netherlands.","authors":"J F Broekmans","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The elimination of tuberculosis in the Netherlands is not envisaged before 2025. The evidence presented in this paper suggests that the elimination phase asks for a revision of existing control strategies. In the Netherlands a new role is identified for a voluntary tuberculosis organisation like the Royal Netherlands Tuberculosis Association (KNCV) in the areas of expert consultation, surveillance, post-graduate education and consensus and protocol development. A major challenge for a low prevalence country is the existence of high prevalence countries; KNCV's contribution to the success of the Mutual Assistance Programme of the IUATLD in Tanzania, Malawi, Benin, Kenya and Mali is discussed. A major role is identified for the IUATLD and voluntary organisations like KNCV in WHO's new global programme against tuberculosis. The involvement of a Dutch voluntary organisation, the Medical Committee The Netherlands-Vietnam (MCNV) in support of the national tuberculosis programme in Vietnam illustrates this development.</p>","PeriodicalId":77502,"journal":{"name":"Bulletin of the International Union against Tuberculosis and Lung Disease","volume":"66 4","pages":"179-83"},"PeriodicalIF":0.0000,"publicationDate":"1991-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of the International Union against Tuberculosis and Lung Disease","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The elimination of tuberculosis in the Netherlands is not envisaged before 2025. The evidence presented in this paper suggests that the elimination phase asks for a revision of existing control strategies. In the Netherlands a new role is identified for a voluntary tuberculosis organisation like the Royal Netherlands Tuberculosis Association (KNCV) in the areas of expert consultation, surveillance, post-graduate education and consensus and protocol development. A major challenge for a low prevalence country is the existence of high prevalence countries; KNCV's contribution to the success of the Mutual Assistance Programme of the IUATLD in Tanzania, Malawi, Benin, Kenya and Mali is discussed. A major role is identified for the IUATLD and voluntary organisations like KNCV in WHO's new global programme against tuberculosis. The involvement of a Dutch voluntary organisation, the Medical Committee The Netherlands-Vietnam (MCNV) in support of the national tuberculosis programme in Vietnam illustrates this development.